In summary, our results indicate that MSTRG.29039.1 is highly expressed in MM patients and can potentially competitively bind to hsa-miR-12119, leading to the overexpression of OSMR, reducing apoptosis, and promoting proliferation. This evidence concerns the gene OSMR and Miyoshi myopathy.